Focusing on the Core of Biopharmaceutical Manufacturing: A Journey Through Upstream and Downstream Technologies
With the rapid advancement of biotechnology, biopharmaceuticals, as a crucial component of modern healthcare, are driving significant growth in the global biologics market. According to the latest data from third-party institutions, the global biologics market was valued at $537.54 billion in 2025 and is projected to reach $1,796.21 billion by 2034, representing a compound annual growth rate (CAGR) of 14.36%.
Croda Health Care, a trusted and seasoned partner in the field of biopharmaceutical manufacturing, leverages decades of experience in excipient production and purification to provide customers with professional, innovative solutions for biopharmaceutical manufacturing.
To promote technical exchange and collaboration within the industry, we will host a series of thematic seminars on biopharmaceutical manufacturing, conducted via live online streaming.
This seminar will be divided into two sessions, focusing onUpstream Cell CultureandDownstream Production Process。
Cell culture is a critical step in the upstream production of biopharmaceuticals. Enhancing cell viability and growth rates, as well as optimizing cell culture processes, play pivotal roles in cell line development and large-scale cultivation. We will explore the mechanism of action of Poloxamer 188 in cell culture, as well as the impact of impurities and molecular weight on cellular processes.
New Launch: Croda Super Refined™ High-Purity Poloxamer 188– Designed for Cell Culture Optimization
Time: Thursday, March 20, 2025, 15:00-16:00
Live Stream Highlights:
● What is the mechanism of action of Poloxamer 188 in cell culture processes?
● What are the challenges associated with the selection and use of Poloxamer 188 in cell culture processes?
● How to Select the Appropriate Poloxamer 188 to Enhance Cell Viability, Growth Rate, and Product Expression in Cell Culture?
● Croda Poloxamer 188What are the advantages?
Speaker:
Hu Shichen, Senior Application Engineer at Croda Healthcare
Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences; Ph.D. in Chemical Biology; with extensive experience in downstream process development for biopharmaceuticals.
Watch the Livestream, Win Great Prizes:
Scan the QR code below to register and sign up immediately.
Look forward to discussing and exchanging ideas with you!